Cortexyme, Inc

United States of America

 
Total IP 11
Total IP Rank # 141,014
IP Activity Score 1.1/5.0    3
IP Activity Rank # 344,065
Stock Symbol
ISIN US22053A1079
Market Cap. 1,400M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

2 0
0 0
8 0
1
 
Last Patent 2022 - Arginine gingipain inhibitors
First Patent 2015 - Methods of use for therapeutics ...
Last Trademark 2018 - CORTEXYME
First Trademark 2018 - CORTEXYME

Industry (Nice Classification)

Latest Inventions, Goods, Services

2021 Invention Compositions and methods for treatment of coronavirus infection. Compounds and methods for the tr...
Invention Aminopyridine compounds and methods for the preparation and use thereof. The present invention r...
2020 Invention Arginine gingipain inhibitors. Therapeutics targeting the bacterium Porphyromonas gingivalis, in...
Invention Arginine gingipain inhibitors. Therapeutics targeting the bacterium Porphyromonas gingivalis, inc...
Invention Arginine gingipain inhibitors. Porphyromonas gingivalisP. gingivalisP. gingivalis infection, incl...
2019 Invention Methods for detection of microbial nucleic acids in body fluids. Methods for detecting microbial...
Invention Methods for detection of microbial nucleic acids in body fluids. Porphyromonas gingivalis, e.g.Po...
2018 G/S Pharmaceutical preparations for the treatment and prevention of Alzheimer's, brain disorders, neu...
Invention Aminopyridine compounds and methods for the preparation and use thereof. The present invention re...
Invention Aminopyridine compounds and methods for the preparation and use thereof. The present invent...
2017 Invention Ketone inhibitors of lysine gingipain. The present invention provides compounds according to Form...
Invention Treatment of osteoarthritis with gingipain blocking agents. The invention provides methods for tr...
2016 Invention Inhibitors of arginine gingipain. The present invention relates generally to therapeutics targeti...
2015 Invention Inhibitors of lysine gingipain. The present invention relates generally to therapeutics targeting...
Invention Methods of use for therapeutics targeting the pathogen porphyromonas gingivalis. The invention r...